Cancer Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2029

  • Single User License $3500

Cancer Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 – 2029

Status : May, 2021 | Biotechnology

Report Digest


Cancer Biopsy Market: Overview

Biopsies have remarkably advanced the molecular medicine in general and oncology in particular. Technological strides in the devices used for biopsies have considerably improved the molecular characterization of cancers. They have been used popularly to diagnose the malignancy, identify the histology of the tumor, and also in staging of cancer. The expanding vistas of molecular medicine paved the way to the development of new devices. A notable case in point is image-guided percutaneous biopsies used in lung cancer. The growing assays of molecular assays is key to evolution of cancer biopsy market. In clinical trials, biopsies are used to determine response rates of drugs, notably for patients receiving epidermal growth factor receptor (EGFR) therapies. Growing number of clinical trials in biomarker studies has helped in the evolution of the cancer biopsy market.

Cancer Biopsy Market: Key Trends

An emerging technology is fine needle aspiration biopsies, which is increasingly being incorporated in different types of cancer notably including breast cancer, lung cancer, colorectal cancer, blood cancer, and thyroid cancer. The growing popularity of multi-parametric magnetic resonance (MR) imaging-based biopsies is due to the benefits they offer. The growing role of image-guided needle biopsies in precision medicine is a key trend boosting the market. The circulating tumor cells (CTCs) have high diagnostic potential in cancer.

Another emerging paradigm is liquid biopsy of cancer. The minimally invasive nature of extraction of circulating tumor cells (CTCs) has made it a popular investigative tool in lung cancer, particularly in patients with lung adenocarcinoma. However, their isolation poses challenges to radiologists. Advancing techniques in next-generation sequencing are boosting the growth of the market.

Cancer Biopsy Market: Competitive Assessment

Over the years, clinicians have successfully used molecular biomarkers in prognosis of various cancer types. The demand for interventional oncology procedures has also gathered pace on the back of advances made in image-guidance technologies. Companies pioneering in bioinformatics are increasing their stakes in the cancer biopsy market. They are launching advanced bioinformatics platforms to make data analytics more useful for clinician and patients in oncology. Meanwhile, growing focus on Human Genome Project on understanding personalized patterns of tumor also bodes well for the market.

A growing body of multidimensional research on the role of biopsies in molecular medicine will expand the avenue for aspiring players in the cancer biopsy market. Some of the key players in the cancer biopsy market are Chronix Biomedical, Inc., Epigenomics AG, Freenome Holdings, Inc., Guardant Health, Lucence Diagnostics Pte. Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Biocept, Inc., Hologic, Inc., Myriad Genetics, and ANGLE Plc.

Cancer Biopsy Market: Regional Assessment

On the regional front, North America has been offering some incredible opportunities for industry players and other stakeholders. A large chunk of the revenues in recent years came from the U.S. A favorable framework engendered by the regulatory agencies of the region also has encouraged the spirit of innovations for biotech companies in the cancer biopsy market. The regional market has also received growth impetus from the strides made by precision medicine in oncology. Extensive demand for biopsies in interventional oncology procedures has also fueled revenue generation in the overall market.

On the other hand, Asia Pacific is emerging at rapid pace. Its growth has been continuously expanding from the growth awareness about the morbidity of cancer. The prevalence of breast cancer has also fueled the demand for biopsies, and a favorable reimbursement and payers’ networks are trend boosting the growth potential of the region in the global cancer biopsy market.

This study provides a particularized anatomy according to the L.E.A.P mechanism

  • Latest trends and cardinal growth prospects
  • Existing and future insights in growth
  • Ascensions in technology
  • Pain points

The regional analysis offers market assays across:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study, prepared through the L.E.A.P mechanism adds a dimension of infallibility and assures precise information on all the growth dynamics.

Latest Trends and Cardinal Growth Prospects

The study assists in burnishing the knowledge of the stakeholder in terms of the emerging trends. The study provides an expansive coverage on the latest developments and novel profit-yielding sources that augur well with the market. A dedicated and determined team of experts conduct an out-and-out research on diverse aspects to offer ultimate breakthroughs in the market.

Existing and Future Insights in Growth

The interfusion of ubiquitous primary and secondary research through modern tools invites perfection and accuracy in every aspect. Primary research is circumspectly conducted through exhaustive interactions and interviews of experts. These valuable opinions are then neatly inducted in the report to allow the stakeholder for reaping the benefits. A treasure of secondary data is extracted via famed paid sources, yearly estimates and statements, renowned journals, and government documents. These sources assist in creating a robust database comprising existing and subsequent growth dynamics.

Ascensions in Technology

Diverse technological advancements and cutting-edge innovations in the market have been covered in this study to assist the stakeholder in research and development activities. Recent upgrades have also been added in the study, thus helping the stakeholder to paint the strokes of growth on the canvas of the market.

Pain Points

The study presents a plethora of challenges and obstacles that can hinder the growth of the market to allow the stakeholder to prepare their strategies accordingly.

The world ushered in the new decade with the shadow of the COVID-19 pandemic. The outbreak has damaged the growth prospects of several businesses and has crippled the entire economy. The study is in tandem with the changing dynamics of the market due to the SARS-CoV-2 outbreak. The study focuses on the coronavirus pandemic and analyses every aspect that impacts the growth positively or negatively.

An aerial perspective of the regions covered in this study enables the stakeholder to design strategies accordingly. The 360-degree assessment of every aspect associated with growth offers information on a rainbow of growth opportunities available across the market.

The exhaustive study motivates the stakeholder to take the 'LEAP' of faith and achieve success!

This report is the key to questions such as:

What are the prominent factors that will help in reshaping the market growth?

Which trends have the potential to bring expansive growth for the market?

What are the necessary strategies to overcome the ill-effects of the COVID-19 pandemic?

Which regions will emerge as champion growth contributors for the market?

Which aspects will serve as game-changers for the market?

What are the latest innovations in the market?

Which factors will hinder the growth of the market?